[Federal Register Volume 84, Number 33 (Tuesday, February 19, 2019)]
[Notices]
[Page 4858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02694]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on
April 3-4, 2019. A sample of agenda items to be discussed during the
public session includes: A discussion on medical-related events; a
discussion on the ACMUI's recommendations and comments on revision 10
of the draft Yttrium-90 Microsphere Brachytherapy Sources and Devices
TheraSphere[supreg] and SIR_Spheres[supreg] Licensing Guidance; a
discussion on the summary of changes to the NRC's requirements
regarding medical use of byproduct material; a discussion of the
ACMUI's recommendations related to the appropriateness of the required
reporting and notification of a medical event; a presentation from
Lucerno Dynamics on the detection of nuclear medicine injection
infiltrations; and a discussion on the ACMUI's recommendations and
comments on the draft Germanium-68/Gallium-68 Pharmacy Grade Generator
Licensing Guidance. The agenda is subject to change. The current agenda
and any updates will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html or by emailing Ms. Kellee Jamerson
at the contact information below.
FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, email:
[email protected], telephone: (301) 415-7408.
SUPPLEMENTARY INFORMATION:
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time for Open Sessions: April 3, 2019, from 8:30 a.m. to
2:45 p.m. and April 4, 2019, from 8:30 a.m. to 2:45 p.m. Eastern
Standard Time.
Date and Time for Closed Session: April 3, 2019, from 2:45 p.m. to
5:00 p.m. Eastern Standard Time.
Address for Public Meeting: U.S. Nuclear Regulatory Commission,
Three White Flint North Building, Rooms 3WFN-1C03/1-C05, 11601
Landsdown Street, North Bethesda, Maryland 20852.
Public Participation
Any member of the public who wishes to participate in the meeting
in person or via phone should contact Ms. Jamerson using the
information below. The meeting will also be webcast live at https://video.nrc.gov/.
Conduct of the Meeting
Christopher J. Palestro, M.D., will chair the meeting. Dr. Palestro
will conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to
Ms. Jamerson using the contact information listed above. All
submittals must be received by March 29, 2019, three business days
before the meeting, and must pertain to the topics on the agenda for
the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html on or about May 16, 2019.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Jamerson of their planned
attendance.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland, on February 13, 2019.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-02694 Filed 2-15-19; 8:45 am]
BILLING CODE 7590-01-P